Compare VanEck Gold Miners ETF (GDX) vs Merck & Co., Inc. (MRK) Price & Performance

VanEck Gold Miners ETFTrade

Merck & Co., Inc.Trade

Price performance (Past 24H)

Key statistics

VanEck Gold Miners ETF vs Merck & Co., Inc. — how do they compare? VanEck Gold Miners ETF trades at $71.24, while Merck & Co., Inc. trades at $128.05 (market cap $305.29B). The key difference: Merck & Co., Inc. pays a 2.75% dividend while VanEck Gold Miners ETF pays none, and Merck & Co., Inc. is trading nearer its 52-week high, VanEck Gold Miners ETF nearer its low. Which is the better fit depends on your goals.

	GDX	MRK
52-Week High	$115.84	$129.52
52-Week Low	$51.15	$77.60
Market Cap	—	$305.29B
Sector	—	Health
Enterprise Value	—	$348.71B
Dividend Yield	—	2.75%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

VanEck Gold Miners ETF

No Aura AI signal available yet.

Merck & Co., Inc.

Merck (MRK) trades at $128.00, up 5.96% on the day. The stock shows a bullish technical signal with strong moving average support, while fundamentals reveal robust profitability with a 73.91% gross margin and consistent earnings beats in recent quarters. The company is actively expanding its oncology pipeline through acquisitions, most notably the $6.7 billion tender offer for Terns Pharmaceuticals announced in April 2026.

The outlook is positive, supported by strong analyst consensus (67.57% Buy rating) and a price target implying ~7% upside. Key opportunities include pipeline expansion via M&A and solid cash flow generation. Primary risks involve integration of large acquisitions, patent cliffs for key drugs, and intense competition in the oncology space, which could pressure future growth margins.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GDX

Gold prices may fall further to $3,600 but offer buying chances, says Bank of America.Kitco · 6 hours agoNeutral VanEck Gold Miners ETF underperforms cheaper rivals and physical gold over 10 years despite higher fees.24/7 Wall Street · 1 day agoNeutral View details →

MRK

FDA approves Merck's first oral PCSK9 inhibitor pill for lowering cholesterol, expanding treatment options.New York Post · 4 hours agoBullish View details →

About VanEck Gold Miners ETF

The fund normally invests at least 80% of its total assets in common stocks and depositary receipts of companies involved in the gold mining industry. The index is a modified market-capitalization weighted index primarily comprised of publicly traded companies involved in the mining for gold and silver. The fund is non-diversified.

About Merck & Co., Inc.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.